Cozad Asset Management Inc Biogen Inc. Transaction History

Cozad Asset Management Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$193.77 - $244.14 $159,666 - $201,171	-824 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$223.92 - $287.77 $66,504 - $85,467	-297 Reduced 26.49%	824 $198,000
Q2 2021 Jul 29, 2021	SELL	$259.0 - $414.71 $22,274 - $35,665	-86 Reduced 7.13%	1,121 $388,000
Q1 2021 Apr 29, 2021	BUY	$242.95 - $284.63 $20,893 - $24,478	86 Added 7.67%	1,207 $338,000
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $21,027 - $31,651	-89 Reduced 7.36%	1,121 $274,000
Q3 2020 Oct 28, 2020	SELL	$264.77 - $305.71 $97,170 - $112,195	-367 Reduced 23.27%	1,210 $343,000
Q2 2020 Aug 07, 2020	SELL	$258.66 - $342.55 $394,715 - $522,731	-1,526 Closed	0 $0
Q4 2019 Jan 16, 2020	SELL	$220.06 - $304.07 $3,300 - $4,561	-15 Reduced 0.97%	1,526 $453,000
Q3 2019 Oct 31, 2019	SELL	$217.44 - $243.88 $12,828 - $14,388	-59 Reduced 3.69%	1,541 $359,000
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $178,721 - $197,001	-815 Reduced 33.75%	1,600 $374,000
Q1 2019 Apr 18, 2019	SELL	$216.71 - $338.96 $10,402 - $16,270	-48 Reduced 1.95%	2,415 $571,000
Q4 2018 Jan 14, 2019	BUY	$278.5 - $352.75 $66,004 - $83,601	237 Added 10.65%	2,463 $741,000
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $20,545 - $26,868	-70 Reduced 3.05%	2,226 $786,000
Q2 2018 Aug 15, 2018	BUY	$257.52 - $306.91 $591,265 - $704,665	2,296 New	2,296 $666,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Cozad Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cozad Asset Management Inc with notifications on news.